Genes in panel
STRs in panel
Prev Next

COVID-19 research

Gene: ADAM17

Green List (high evidence)

ADAM17 (ADAM metallopeptidase domain 17)
EnsemblGeneIds (GRCh38): ENSG00000151694
EnsemblGeneIds (GRCh37): ENSG00000151694
OMIM: 603639, Gene2Phenotype
ADAM17 is in 6 panels

6 reviews

Eleanor Williams (Genomics England Curator)

Provisionally associated with ?Inflammatory skin and bowel disease, neonatal, 1 #614328 (AR) in OMIM.

PMID: 22010916 - Blaydon et al 2011 - report 2 siblings with neonatal-onset inflammatory skin and bowel disease. The parents were consanguineous of Lebanese origin. One sibling died age 12 from fulminant parvovirus B19–associated myocarditis. A homozgyous 4 bp in exon 5 of ADAM17 (c.603–606delCAGA) segregated with the disease in this family; it was predicted that the mutation would introduce a frame shift and a premature stop codon (p.Asp201GlufsX11). The mutation is predicted to result in a protein that lacks all functional domains. There was reduced expression of ADAM17 in the affected brothers skin and small intestine.

PMID: 26683521 - Tsukerman et al 2015 - report a proband with consangiuneous parents with recurrent infections. He died at two years of age of respiratory failure and presumed sepsis. A homozygous deletion of exon 1 of ADAM17 was found. NK cells from the patient lacked ADAM17 protein expression. CD16 activity on the patient's NK cells is enhanced. In the study of Blaydon et al and in this study TNFα was barely secreted by the patient and in both cases this was accompanied by severe bacteremia.

PMID: 25804906 - Bandsma et al 2015 - report a proband presented with severe diarrhea, skin rash, and recurrent sepsis, eventually leading to her death at the age of 10 months. Exome sequencing identified a novel homozygous frameshift mutation in ADAM17 (NM_003183.4:c.308dupA) leading to a premature stop codon. CD4+ and CD8+ T-cell stimulation assays showed severely diminished tumor necrosis factor–α and interleukin-2 production.

PMID: 29560122 - Fuchslocher Chico et al 2018 - mouse model. ADAM17 knockout is lethal in mice, but hypomorphic ADAM17ex/ex mice have been created that express only ~5% of the original levels of ADAM17 in all tissues. These mice have increased susceptibility to dextran sulfate sodium (DSS)-induced colitis. They identify ADAM17 as a novel regulator of necroptosis.

Summary: 3 cases plus mouse model. Green review from Zornitza Stark on the PID panel.
Created: 23 Apr 2020, 1:49 a.m. | Last Modified: 23 Apr 2020, 1:49 a.m.
Panel Version: 0.137

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
?Inflammatory skin and bowel disease, neonatal, 1 #614328

Publications

Abdelazeem Elhabyan (Arizona State University)

I don't know

The mutation is found to decrease the ADAM17 function which is needed for TNF-alpha production which is needed for antiviral activity.

PMID: 11773383 Tumor Necrosis Factor Alpha Exerts Powerful Anti-Influenza Virus Effects in Lung Epithelial Cells
The mutation causes a decrease in the TNF-alpha levels which is important for comparing the Influenza virus of all types(avian, swine, and human). the antiviral effect of TNF-α was greater than that of gamma or alpha interferon.

The loss of function mutation relevance to viral infection is related to parvovirus B19 infection in the girl. No other virus susceptibility is noted.


The girl died suddenly at 12 years of age from parvovirus B19–associated myocarditis; her brother had mild cardiomyopathy
We identified a loss-of-function mutation in ADAM17, which encodes a disintegrin and metalloproteinase 17 (also called tumor necrosis factor α [TNF-α]–converting enzyme, or TACE), as the probable cause of this syndrome. Peripheral-blood mononuclear cells (PBMCs) obtained from the brother at 17 years of age showed high levels of lipopolysaccharide-induced production of interleukin-1β and interleukin-6 but impaired release of TNF-α.
Created: 7 Apr 2020, 8:38 p.m. | Last Modified: 7 Apr 2020, 8:38 p.m.
Panel Version: 0.61

Kimberly Gilmour (Great Ormond Street Hopsital)

I don't know

agree with all the Amber genes
Created: 25 Sep 2019, 1:49 p.m. | Last Modified: 25 Sep 2019, 1:49 p.m.
Panel Version: 1.115

Tracy Briggs (Manchester Genomic Medicine Centre)

I don't know

The amber genes are covered on our targeted exome, we feel that these should be covered in the testing
Created: 25 Sep 2019, 1:44 p.m. | Last Modified: 25 Sep 2019, 1:44 p.m.
Panel Version: 1.114

Sophie Hambleton (Newcastle University)

I don't know

Single kindred (2 siblings) described with skin and gut inflammation. Full mouse knockout not viable; conditional knockout recapitulates intestinal inflammation upon challenge with DSS
Created: 19 Jun 2018, 4:52 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Louise Daugherty (Genomics England Curator)

I don't know

Inflammatory skin and bowel disease neonatal: one family, moderately elevated IgE, no evidence of immunodeficiency although nail, ear, eye infections - a phenocopy? Phenotypic opinion? Amber on association
Created: 26 Sep 2019, 3:49 p.m. | Last Modified: 26 Sep 2019, 3:49 p.m.
Panel Version: 1.130
Gene rating submitted by Tracy Briggs, David Gokhale and Abigal Rousseau on behalf of North West GLH for the GMS Immunology specialist test group. As discussed with the GMS Immunology Specialist Test Group during webex call 28th March 2019 and confirmed in follow up email on 20th June the Specialist Test Group all agreed there is only enough evidence to rate this gene Amber.
Created: 25 Sep 2019, 3 p.m. | Last Modified: 25 Sep 2019, 3 p.m.
Panel Version: 1.116
Gene rating submitted by Kimberly Gilmour and Austen Worth on behalf of London North GLH for the GMS Immunology specialist test group. As discussed with the GMS Immunology Specialist Test Group during webex call 28th March 2019 and confirmed in follow up email 6th September the Specialist Test Group all agreed there is only enough evidence to rate this gene Amber
Created: 25 Sep 2019, 3 p.m. | Last Modified: 25 Sep 2019, 3 p.m.
Panel Version: 1.116
OriginaI Metadata from IUIS classification table (February, 2018) downloaded 20180614. IUIS Genetic defect (original gene symbol in IUIS download): ADAM17 .PanelApp HGNC gene symbol check: ADAM17 . IUIS Disease: ADAM17 deficiency . IUIS Inheritance: AR .T cells: N/A, .B cells: N/A, .IUIS Other affected cells: Leukocytes and epithelial cells. IUIS Associated features: Early onset diarrhea and skin lesions. IUIS Major category: Autoinflammatory Disorders. IUIS Subcategory: Non-Inflammasome Related Conditions
Created: 2 Jul 2018, 10:35 a.m.
After further comments from external clinical expert review this gene will remain Amber until more info on gene and disease association.
Created: 20 Jun 2018, 2:43 p.m.
Reviewed and decided to keep as amber until further evidence in the literature or from external expert review input. The gene is on both the GRID and GOSH diagnostic panels for neonatal Inflammatory skin and bowel disease.
Created: 1 May 2018, 10:38 a.m.
Immunodeficiency caused by hypomorphic mutations in ADAM17 deficiency cause epithelial and immune dysfunction. Only one family report found an affected brother and sister from a consanguineous family of Lebanese origin with neonatal inflammatory skin and bowel disease1, PMID: 22010916 (2011). Genetic deficiency of ADAM17 has been linked to neonatal inflammatory skin and bowel disease, yet the pathogenic mechanisms remain unclear. ADAM17 is likely critical for the maintenance of mucosal epithelial barriers, as shown by the defective regeneration of intestinal epithelial cells in response to experimental colitis in hypomorphic ADAM17 animal models. There is functional/mouse model evidence to support the association, and ADAM17 is known to have a role in controlling inflammation and tissue regeneration (PMID: 21752713). The phenotype was also rescued by treatment with EGFR ligands, further supporting ADAM17 maintaining epithelial barriers by providing soluble EGFR ligands.
Created: 1 May 2018, 9:45 a.m.
Comment on phenotypes: added phenotype and MIMid from OMIM
Created: 30 Apr 2018, 4:32 p.m.
Comment on publications: added publications to support phenotype of Inflammatory skin and bowel disease, neonatal.
Created: 30 Apr 2018, 4:30 p.m.
This gene was absent from the original PanelApp PID panel dataset (review April 2018). However it was listed in external expert immunodeficiency diagnostic gene list(s) GOSH or GRID. In this combined PID panel, this gene has been rated as AMBER and needs further curational review to assess pertinence prior to v1.
Created: 20 Apr 2018, 12:25 p.m.
Original metadata supplied by GRID. GRID Gene Symbol HGNC PanelApp check: ADAM17, GRID_Gene_Symbol: ADAM17, GRID_Transcript_ENS_Community submitted: ENST00000310823, GRID_Transcript_RefSeq: NM_003183.4, GRID_Transcript_ENS_used_on_Production: ENST00000310823
Created: 17 Apr 2018, 12:12 p.m.

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
Phenotypes
  • IBD-1
  • ADAM17 deficiency
  • Inflammatory skin and bowel disease, neonatal, 1
  • Inflammatory skin and bowel disease, neonatal 1, 614328
  • Autoinflammatory Disorders
  • inflammatory skin
  • Early onset diarrhea and skin lesions
OMIM
603639
Clinvar variants
Variants in ADAM17
Penetrance
None
Publications
Panels with this gene

History Filter Activity

23 Apr 2020, Gel status: 3

Set publications

Rebecca Foulger (Genomics England curator)

Publications for gene: ADAM17 were set to 22010916; 20603312; 25058236; 32086639; 11149563; 28930861; 32048120; 25171914

2 Apr 2020, Gel status: 3

Added New Source, Set Phenotypes, Status Update

Ellen McDonagh (Genomics England Curator)

Source Expert Review Green was added to ADAM17. Added phenotypes IBD-1; ADAM17 deficiency; Inflammatory skin and bowel disease, neonatal, 1; Inflammatory skin and bowel disease, neonatal 1, 614328; Autoinflammatory Disorders; inflammatory skin; Early onset diarrhea and skin lesions for gene: ADAM17 Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

1 Apr 2020, Gel status: 2

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Ellen McDonagh (Genomics England Curator)

gene: ADAM17 was added gene: ADAM17 was added to Viral susceptibility. Sources: Victorian Clinical Genetics Services,North West GLH,GRID V2.0,NHS GMS,GOSH PID v.8.0,London North GLH,IUIS Classification December 2019,IUIS Classification February 2018,Expert Review Amber Mode of inheritance for gene: ADAM17 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ADAM17 were set to 22010916; 20603312; 25058236; 32086639; 11149563; 28930861; 32048120; 25171914 Phenotypes for gene: ADAM17 were set to IBD-1; ADAM17 deficiency; Inflammatory skin and bowel disease, neonatal, 1; Inflammatory skin and bowel disease, neonatal 1, 614328; Autoinflammatory Disorders; inflammatory skin; Early onset diarrhea and skin lesions